Back to
American Century Companies Inc.
RIGL
Showing 0 of 6 quarters
Position history for
American Century Companies Inc.'s holdings in Rigel Pharmaceuticals, Inc.
No. American Century Companies exited its RIGL (Rigel Pharmaceuticals) position in Q1 2023. Its Q4 2022 13F listed 15,501 shares worth $23,252. American Century Companies first reported RIGL in Q3 2021 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.